Spectrum of Malignant Pleural and Pericardial Disease on FDG PET/CT

被引：14

作者：

Makis, William ^{[1
]}

Ciarallo, Anthony ^{[2
]}

Hickeson, Marc ^{[2
]}

Rush, Christopher ^{[3
]}

Novales-Diaz, Javier A. ^{[2
]}

Derbekyan, Vilma ^{[2
]}

Laufer, Jerome ^{[3
]}

Stern, Jerry ^{[3
]}

Lisbona, Robert ^{[2
]}

机构：

[1] Brandon Reg Hlth Ctr, Dept Nucl Med, Brandon, MB R7A 2B3, Canada

[2] McGill Univ, Royal Victoria Hosp, Dept Nucl Med, Montreal, PQ H3A 1A1, Canada

[3] McGill Univ, Jewish Gen Hosp, Dept Nucl Med, Montreal, PQ H3T 1E2, Canada

来源：

AMERICAN JOURNAL OF ROENTGENOLOGY | 2012年 / 198卷 / 03期

关键词：

FDG; malignancy; pericardial; PET/CT; pleural; POSITRON-EMISSION-TOMOGRAPHY; PRIMARY EFFUSION LYMPHOMA; METASTATIC INVOLVEMENT; COMPUTED-TOMOGRAPHY; HODGKIN-LYMPHOMA; LUNG-CANCER; MESOTHELIOMA; CT; MANAGEMENT; ABNORMALITIES;

D O I：

10.2214/AJR.11.7076

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

OBJECTIVE. The purpose of this article is to illustrate a wide spectrum of malignant primary and secondary pleural and pericardial diseases imaged with F-18-FDG PET/CT. CONCLUSION. A wide variety of malignant pleural and pericardial diseases can be detected, staged, and monitored by FDG PET/CT. Although the PET/CT findings are often nonspecific, the aim of this atlas is to show that the spectrum of pleural and pericardial disease that can be evaluated with PET/CT is much broader than current literature would suggest. PET/CT readers and oncologists should be aware of the wide variety of malignancies that can affect the pleura and pericardium and some of the patterns of FDG uptake that can be observed in these cases.

引用

页码：678 / 685

页数：8

共 37 条

[1] Abraham K P, 1990, Am J Cardiovasc Pathol, V3, P195
[2] Positron emission tomography imaging in nonmalignant thoracic disorders
Alavi, A
Gupta, N
Alberini, JL
Hickeson, M
Adam, LE
Bhargava, P
Zhuang, HM
[J]. SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (04) : 293 - 321
[3] Use of imaging in the management of malignant pleural mesothelioma
Benamore, RE
O'Doherty, MJ
Entwisle, JJ
[J]. CLINICAL RADIOLOGY, 2005, 60 (12) : 1237 - 1247
[4] Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography
Bénard, F
Sterman, D
Smith, RJ
Kaiser, LR
Albelda, SM
Alavi, A
[J]. CHEST, 1998, 114 (03) : 713 - 722
[5] FDG PET in primary effusion lymphoma (PEL) of the pericardium
Bhargava, P
Glass, E
Brown, J
Eapen, E
Ames, E
[J]. CLINICAL NUCLEAR MEDICINE, 2006, 31 (01) : 18 - 19
[6] FDG PET for imaging pericardial manifestations of Hodgkin lymphoma
Buchmann, I
Wandt, H
Wahl, A
Reske, SN
[J]. CLINICAL NUCLEAR MEDICINE, 2003, 28 (09) : 760 - 761
[7] Powerful prognostic stratification by [18F] fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy
Cachin, Florent
Prince, H. Miles
Hogg, Annette
Ware, Robert E.
Hicks, Rodney J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3026 - 3031
[8] 18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study
Carretta, A
Landoni, C
Melloni, G
Ceresoli, GL
Compierchio, A
Fazio, F
Zannini, P
[J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2000, 17 (04) : 377 - 382
[9] Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose
Ceresoli, Giovanni L.
Chiti, Arturo
Zucali, Paolo A.
Rodari, Marcello
Lutman, Romano F.
Salamina, Silvia
Incarbone, Matteo
Alloisio, Marco
Santoro, Armando
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) : 4587 - 4593
[10] Metastatic involvement of the heart and pericardium: CT and MR imaging
Chiles, C
Woodard, PK
Gutierrez, FR
Link, KM
[J]. RADIOGRAPHICS, 2001, 21 (02) : 439 - 449

← 1 2 3 4 →